SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
"While this is a positive short-term development, no one can rest easy when our ability to get this safe, effective medication for abortion and miscarriage care still hangs in the balance," stressed an ACLU attorney.
The US Supreme Court on Monday temporarily restored access to mifepristone, a medication commonly used for abortion and early miscarriage care, through the mail while the justices review a decision requiring it to be dispensed in person by a medical provider.
Justice Samuel Alito, who is part of the high court's right-wing supermajority, oversees the US Court of Appeals for the 5th Circuit. He issued a one-week stay for the appellate court's Friday dispensing decision, which critics had condemned as "sweeping and dangerous."
"This is not particularly surprising from Alito. He's the circuit justice here, acting—in essence—until the full court can act," explained Law Dork's Chris Geidner. He noted that both Alito and Justice Clarence Thomas, another right-winger, "have issued administrative stays in the past until the full court can rule in similar circumstances, regardless of their ultimate votes on the matters."
The drug companies Danco Laboratories, which makes the brand-name version of mifepristone, Mifeprex, and GenBioPro, which makes the generic pill, asked the country's top court to intervene following Friday's ruling, which threatened patients nationwide.
"Even this Supreme Court can see that this 5th Circuit decision is reckless," declared Alexis McGill Johnson, president and CEO of Planned Parenthood Action Fund, on Monday. "While mifepristone access returns to where it was on Friday morning, the whiplash and chaos that patients and providers are navigating have already had real consequences for real people's lives and futures."
Brittany Fonteno, president and CEO of the National Abortion Federation, similarly highlighted how "this back-and-forth has created confusion and chaos," but welcomed that the high court's "decision provides critical, if temporary, relief for patients and providers and ensures that people can continue to access this essential medication through telehealth while the court considers the case."
"The lower court's ruling disregards the well-established safety and efficacy of the use of mifepristone via telehealth, and any future restriction will create medically unnecessary barriers to care for patients across the country," Fonteno added. "Mifepristone has been safely used for more than 25 years, and is essential to abortion care and miscarriage management in the United States. For many patients, especially those in rural areas or facing financial and logistical barriers, access to telehealth is a critical component of holistic reproductive healthcare."
Since the Supreme Court reversed Roe v. Wade in June 2022, the anti-choice movement and right-wing politicians have ramped up attacks on reproductive freedom at the state level. Meanwhile, the Biden administration's Food and Drug Administration (FDA) permanently lifted mifepristone's in-person dispensing requirement in early 2023, allowing doctors in pro-choice states to serve patients across the country via telehealth and the mail, regardless of local laws.
Louisiana responded to the eased restrictions on mifepristone—which is generally taken with another drug, misoprostol, for abortions—by suing, which led to the battle that has now reached the Supreme Court. Prior to Friday's decision by the infamously far-right 5th Circuit, a district judge in the state paused the case due to what the ACLU on Monday called "a sham FDA review announced by the Trump administration," which is ongoing.
"While this is a positive short-term development, no one can rest easy when our ability to get this safe, effective medication for abortion and miscarriage care still hangs in the balance," Julia Kaye, senior staff attorney for the ACLU's Reproductive Freedom Project, stressed Monday. "The Supreme Court needs to put an end to this baseless attack on our reproductive freedom, once and for all."
This article has been updated with comment from the National Abortion Federation.
The "politically driven" ruling, warned one campaigner, "overrides medical expertise and years of research, and threatens to upend how abortion care is delivered nationwide."
Rights advocates swiftly sounded the alarm on Friday after the infamously far-right US Court of Appeals for the 5th Circuit temporarily blocked a federal rule allowing mifepristone to be dispensed by mail, dramatically curtailing access to the medication—commonly used for abortion and early miscarriage care—nationwide, particularly in states with policies hostile to reproductive freedom.
Just months after the US Supreme Court's right-wing supermajority reversed Roe v. Wade, the Food and Drug Administration permanently lifted mifepristone's in-person dispensing requirement in early 2023, under then-President Joe Biden. Louisiana—which has among the nation's most restrictive abortion policies—challenged the FDA's move.
A federal judge in Louisiana paused that lawsuit last month while President Donald Trump's administration conducts an FDA review that seems "designed to manufacture an excuse for further restricting medication abortion across the country," as Julia Kaye, senior staff attorney for the ACLU's Reproductive Freedom Project, warned at the time.
After a panel from the appellate court overturned that decision and revived the in-person dispensing rule on Friday, Kaye declared that "anti-abortion politicians have just made it much harder for people everywhere in the country to get a medication that abortion and miscarriage patients have been safely using for more than 25 years."
"Louisiana's legal attack on mifepristone shamelessly packaged lies and propaganda as an excuse to restrict abortion—and the 5th Circuit rubber-stamped it," she continued. "This decision defies clear science and settled law and advances an anti-abortion agenda that is deeply unpopular with the American people. For countless people, especially those who live in rural areas, face intimate partner violence, or live with disabilities, losing a telemedicine option will mean losing access to this vital medication altogether."
Brittany Fonteno, president and CEO of the National Abortion Federation (NAF), similarly stressed that "this ruling is a sweeping and dangerous rollback that disregards the well-established safety and efficacy of the use of mifepristone via telehealth, and will create immediate, medically unnecessary barriers to care for patients across the country."
"Make no mistake: This ruling is not grounded in science or patient safety," she said. "It is a politically driven decision that overrides medical expertise and years of research, and threatens to upend how abortion care is delivered nationwide. Through this litigation, Louisiana seeks to impose its cruel abortion ban across the nation—including in states with legal protections for abortion—and today the court has taken an extreme step toward that end."
While pledging that "NAF and our allies will continue to advocate to restore full access to medication abortion," Fonteno reminded patients that mifepristone "remains available in doctors' offices, clinics, and hospitals."
Terrific thread. I’ll just add:1. I think there’s a good chance the Supreme Court will stay this decision, allowing providers to keep mailing mifepristone for the time being.2. The Trump administration didn’t want this! Its plan was to wait until after the midterms to crack down on mifepristone.
[image or embed]
— Mark Joseph Stern (@mjsdc.bsky.social) May 1, 2026 at 6:52 PM
After Roe's reversal, the anti-choice movement and its allies in elected offices ramped up efforts to impose state-level restrictions on reproductive healthcare. A significant majority of abortions in the United States involve a two-drug regimen of mifepristone and misoprostol, and a quarter of those patients receive care via telemedicine.
"Telehealth has been the last bridge to care for many seeking abortion, which is precisely why Louisiana officials want it banned," said Nancy Northup, president and CEO of the Center for Reproductive Rights, which joined over 100 other reproductive health, justice, and rights groups, including the ACLU and NAF, that filed an amicus brief in this case.
"This isn't about science—it's about making abortion as difficult, expensive, and unreachable as possible," Northup added. "Telehealth has transformed healthcare. Selectively stripping that away from abortion patients is a political blockade."
The drug companies Danco Laboratories, which makes the brand-name version of mifepristone, Mifeprex, and GenBioPro, which makes the generic, have intervened in Louisiana v. FDA. GenBioPro is represented by the law firm Arnold & Porter and Democracy Forward, whose president and CEO, Skye Perryman, declared Friday that "this is the anti-abortion extremists' playbook in action once again: Weaponize the courts to serve their political interests, ignore decades of scientific evidence proving mifepristone’s safety, and put women directly in harm's way."
"Even as this assault defies the will of the overwhelming majority of the American public, these ideologically extreme politicians and organizations are determined to impose a narrow, autocratic agenda—no matter the cost," she continued, emphasizing that "our fight is not over."
This is a ruling purporting to halt telehealth prescriptions of mifepristone NATIONWIDE. Louisiana asked the Fifth Circuit for a decision by Monday, May 11. That they dropped it on a Friday afternoon feels intentional to keep it in effect for longer. Expect emergency appeal to SCOTUS shadow docket
[image or embed]
— Susan Rinkunas (@susanrinkunas.com) May 1, 2026 at 5:35 PM
The effects of the 5th Circuit's decision are expected to be immediate absent a quick intervention from the Supreme Court, and Nourbese Flint, president of All* Above All, warned that "as always, the people most impacted will be Black and brown communities and those already navigating systemic barriers to care."
Serra Sippel, executive director of the Brigid Alliance, a national abortion support group that helps coordinate and fund travel, said that "we expect to see an immediate increase in patients forced to travel hundreds or even thousands of miles for care. That includes many who are later in pregnancy—when care is more complex and more expensive."
"Over the past several years, we've seen a dramatic rise in abortion travel and a growing reliance on practical support networks like ours, particularly in states where patients already travel long distances for care," Sippel noted. "We will continue to monitor the impact of this ruling and are committed to ensuring abortion patients who need to travel can safely get to the care they need, regardless of where they live."
The cruelty of the blockade on Cuba reveals the heavy humanitarian toll of Unilateral Coercive Measures.
This spring people have been raising awareness of the harms caused by Unilateral Coercive Measures, UCMs or “sanctions”. Sanctions have become the “go-to” foreign policy tool of the United States government, now impacting a quarter of the global economy and one-third of the world’s population. These measures cause an average of 564,000 deaths around the world annually—comparable to the toll from armed conflict—mostly among children under 5 years old.
On April 22 Congress held a briefing on “Humanitarian Impacts of Economic Sanctions, Cuba as a Case Study,” with three outside experts: Mark Weisbrot of the Center for Economic Policy, co-author of the largest study ever conducted on the impacts of sanctions on mortality; David Paul, co-founder of the SanctionsKill campaign, retired nurse practitioner, and co-author of a letter from health workers to Congress about child deaths from sanctions; and Danny Valdes, co-founder of Cuban Americans for Cuba, who shared the perspective of bi-national families impacted by the longstanding and escalating US blockade of Cuba.
Economist Weisbrot said that 71% of the world’s broad economic sanctions are imposed by the United States. These unilateral measures violate international law by deliberately targeting civilian populations for collective punishment in the hope of bringing about regime change, and may even constitute war crimes. In addition to his global study, Weisbrot has compiled research that found US sanctions on Venezuela’s oil industry caused the worst depression in world history outside of wartime, leading to 40,000 excess deaths in just one year, from 2017-2018. And current data on Cuba shows a strained health system and deteriorating health indicators, such as a doubling of infant mortality over the past eight years due to the tightening of the US blockade.
David Paul painted a devastating picture of life in Cuba under escalated coercive measures, especially the fuel blockade which is causing massive power outages and disrupts transportation, the production and distribution of food, refrigeration, water and sanitation, and the operation of ambulances and lifesaving medical equipment. He said this is not an embargo, but an actual blockade of the island. “People in the US government make the false claim that ‘Cuba can buy all the medicines wherever they want.’ It’s a total lie, when in reality all their banking transactions are blocked. [The US] will threaten and punish any corporation—domestic or international—or government, that trades with you. But you are free to buy!”
One parent asked, “Why is the president of the United States deciding whether my son lives or dies?”
More pregnant women are starting prenatal care late and suffering from malnutrition, which results in premature births and low birth weights. More babies are at risk of dying from congenital malformations because of the shortage of functioning diagnostic equipment like ultrasounds needed to detect them. Half of all essential medicines are no longer available in the country, as Cuba cannot even import the raw materials needed to keep its pharmaceutical industry afloat. Children are dying from treatable cancers due to lack of medicines, and physicians are hand-pumping ventilators for their patients when the lights go out. Heartbroken Cuban doctors tell parents, “We know what medicine your daughter needs to treat her cancer, we know where it is, but we can’t get it because they won’t sell it to us.” One parent asked, “Why is the president of the United States deciding whether my son lives or dies?”
Valdes reported an exponential deterioration of conditions on the island between his visits in October 2025 and March 2026, due to the lack of fuel, such as health problems caused by uncollected garbage in the streets of Havana. He says that some blame Cuba exclusively for these troubles, but one cannot deny the role played by US policy. Cuban Americans are impacted because they cannot easily visit relatives or efficiently send them remittances, which can make the difference “between eating and not eating; between accessing medicines and going without.” He noted that the Florida International University poll, running since 1991, reports that 52% of Cuban Americans support the embargo, yet 70% also support the sale of medicine to Cuba. This shows they are not actually in favor of maximum pressure policies.
The host of the briefing, Congresswoman Delia Ramírez (D-Ill.), is a strong proponent of respectful and constructive US foreign policy. She is a leading co-sponsor of H.Res. 1056, which calls for a reset of US relations with Latin America and the Caribbean, including the end of all unilateral economic sanctions. The congresswoman indicated that from Presidents James Monroe to Donald Trump, US interventionism has left a legacy of destruction and distrust, which never leads to peace and democracy.
Congress is gaining awareness of these injustices. A growing number of lawmakers are working to curtail the threat of military force against Cuba, and several signed a statement condemning the ongoing blockade and have endorsed legislation to end it. Some even use the proper terminology, calling for an end to “coercive economic measures.” Are they finally listening to the demands of the American people to end the longest blockade in history? Ever more people are moved to act. During its Congressional Advocacy Day on April 15, Doctors Against Genocide insisted that Cuba be allowed to import medical supplies and pushed legislation to lift the blockade.
We must take advantage of this moment to grow the movement to expose the human cost of sanctions and work to end them. Popular education materials are available on the SanctionsKill website, such as the Sanctions Toolkit. A recent webinar titled “Sanctions Undermine Children’s Right to Health” uses Cuba and Venezuela as case studies to illustrate these impacts and propose a new approach to human rights, such as the Peoples-Centered Human Rights framework.
As stated in the Letter calling on Congress to end child-killing sanctions, “Imposing collective punishment on the innocent is morally reprehensible. It must stop.” Join the fight to end Unilateral Coercive Measures by contacting AmericasWithoutSanctions@gmail.com, a project of the SanctionsKill campaign.